It’s not a secret that activist hedge funds may not represent the interests of a company’s shareholder base. But a report from Institutional Shareholder Services shows that they don’t look like them, either.
Every year, growing companies consider exploring public markets, where they can find the huge benefit of immediate access to capital. But taking that step also can be a large expense, and it can change the way companies operate, what management teams focus on and how autonomous they are. Senior executives making decisions about going public have a lot to think about.
The Securities and Exchange Commission’s Investor Advisory Committee voted to ask the SEC to investigate whether public companies should be required to disclose information around the idea of human capital management. Analysis is underway. While it won’t impact you this proxy season, here’s what you need to know.
2019 could be the year of the human, at least where shareholder proposals are concerned. Proposals this year run the gamut, from talent and diversity, to battling plastics and opioids. A snapshot of four human issues making the rounds at annual meetings.
Expect the pace of private equity-driven healthcare M&A to continue due to available capital and plenty of opportunities across a broad industry.
Another proxy season is underway—leaders beware. Although the usual concerns of corporate governance, executive compensation and regulatory disclosures abound, new, specific worries sit under each of those umbrellas. Under compensation, one proxy advisory firm has a new way to evaluate compensation metrics. Within the disclosure realm, the optics of pay ratio disclosure will continue to create flashy headlines in 2019. Approach with caution.